Patents by Inventor Charlotte Helgstrand

Charlotte Helgstrand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MIC-1 fusion proteins and uses thereof
    Patent number: 9956264
    Abstract: The invention relates to MIC-1 fusion proteins. More specifically it relates to compounds comprising fusion proteins comprising a MIC-1 protein or an analog thereof at the C-terminus of the fusion protein and a functional variant of human serum albumin at the N-terminus of the fusion protein connected via a peptide linker. The compounds of the invention have MIC-1 activity. The invention also relates to pharmaceutical compositions comprising such compounds and pharmaceutically acceptable excipients, as well as the medical use of the compounds.
    Type: Grant
    Filed: January 19, 2016
    Date of Patent: May 1, 2018
    Assignee: Novo Nordisk A/S
    Inventors: Allan C. Shaw, Charlotte Helgstrand, Michael P. Bastner Sandrini, Sebastian B. Joergensen, Henning Thoegersen, Kristian Sass-Oerum, Sven Hastrup, Kim V. Andersen
  • MIC-1 FUSION PROTEINS AND USES THEREOF
    Publication number: 20160129083
    Abstract: The invention relates to MIC-1 fusion proteins. More specifically it relates to compounds comprising fusion proteins comprising a MIC-1 protein or an analogue thereof at the C-terminus of the fusion protein and a functional variant of human serum albumin at the N-terminus of the fusion protein connected via a peptide linker. The compounds of the invention have MIC-1 activity. The invention also relates to pharmaceutical compositions comprising such compounds and pharmaceutically acceptable excipients, as well as the medical use of the compounds.
    Type: Application
    Filed: January 19, 2016
    Publication date: May 12, 2016
    Inventors: Allan C. Shaw, Charlotte Helgstrand, Michael P. Bastner Sandrini, Sebastian B. Joergensen, Henning Thoegersen, Kristian Sass-Oerum, Sven Hastrup, Kim V. Andersen
  • MIC-1 fusion proteins and uses thereof
    Patent number: 9272019
    Abstract: The invention relates to MIC-1 fusion proteins. More specifically it relates to compounds comprising fusion proteins comprising a MIC-1 protein or an analog thereof at the C-terminus of the fusion protein and a functional variant of human serum albumin at the N-terminus of the fusion protein connected via a peptide linker. The compounds of the invention have MIC-1 activity. The invention also relates to pharmaceutical compositions comprising such compounds and pharmaceutically acceptable excipients, as well as the medical use of the compounds.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: March 1, 2016
    Assignee: Novo Nordisk A/S
    Inventors: Allan Christian Shaw, Charlotte Helgstrand, Michael Paolo Bastner Sandrini, Sebastian Beck Joergensen, Henning Thoegersen, Kristian Sass-Oerum, Sven Hastrup, Kim Vilbour Andersen
  • MIC-1 FUSION PROTEINS AND USES THEREOF
    Publication number: 20160015784
    Abstract: The invention relates to MIC-1 fusion proteins. More specifically it relates to compounds comprising fusion proteins comprising a MIC-1 protein or an analogue thereof at the C-terminus of the fusion protein and a functional variant of human serum albumin at the N-terminus of the fusion protein connected via a peptide linker. The compounds of the invention have MIC-1 activity. The invention also relates to pharmaceutical compositions comprising such compounds and pharmaceutically acceptable excipients, as well as the medical use of the compounds.
    Type: Application
    Filed: June 17, 2015
    Publication date: January 21, 2016
    Inventors: Allan Christian Shaw, Charlotte Helgstrand, Michael Paolo Bastner Sandrini, Sebastian Beck Joergensen, Henning Thoegersen, Kristian Saas-Oerum, Sven Hastrup, Kim Vilbour Andersen